Related Experiment Video

Updated: May 26, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
09:41

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract

Published on: June 17, 2014

Structure-based discovery of a novel inhibitor targeting the β-catenin/Tcf4 interaction

Wang Tian1, Xiaofeng Han, Maocai Yan

  • 1Department of Pharmacology, State University of New York, Upstate Medical University, Syracuse, New York 13210, United States.

Biochemistry
|January 10, 2012
PubMed

Insights

A novel compound, BC21, inhibits the Wnt/β-catenin pathway by blocking β-catenin and Tcf4 interaction. This targeted approach shows promise in reducing colon cancer cell viability and proliferation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Aberrant Wnt/β-catenin signaling, driven by β-catenin overexpression, is crucial in tumorigenesis.
  • The interaction between β-catenin and T-cell factor (Tcf) DNA-binding proteins activates proliferative genes.

Purpose of the Study:

  • To identify and characterize a novel small molecule inhibitor targeting the β-catenin/Tcf4 interaction.
  • To evaluate the efficacy of this inhibitor in colon cancer cells with β-catenin overexpression.

Main Methods:

  • Identification of a small molecule inhibitor, BC21.
  • Assay of β-catenin/Tcf4 binding inhibition.
  • Assessment of reporter gene activity.
  • Evaluation of cell viability and clonogenic activity in HCT116 colon cancer cells.
  • Analysis of c-Myc and cyclin D1 expression levels.

Main Results:

  • BC21 effectively inhibits β-catenin binding with Tcf4 and suppresses β-catenin/Tcf4 reporter gene activity.
  • BC21 decreases the viability and clonogenic activity of HCT116 colon cancer cells overexpressing β-catenin.
  • Treatment with BC21 leads to down-regulation of c-Myc and cyclin D1 expression.

Conclusions:

  • BC21 is a potent inhibitor of the β-catenin/Tcf4 interaction.
  • This compound demonstrates significant anticancer potential by targeting a key pathway in colon tumorigenesis.
  • BC21 represents a modifiable scaffold for developing new anticancer therapeutics.

More Related Videos

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase09:51

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase

Published on: June 30, 2023

Protein Target Prediction and Validation of Small Molecule Compound10:21

Protein Target Prediction and Validation of Small Molecule Compound

Published on: February 23, 2024

Related Concept Videos

Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...